Interferon beta but not glatiramer acetate therapy aggravates headaches in MS.
Neurology
; 59(4): 636-9, 2002 Aug 27.
Article
em En
| MEDLINE
| ID: mdl-12196668
ABSTRACT
Type and frequency of headaches during immunomodulatory therapy in MS were determined in 167 consecutive patients. In a prospective group of 65 patients beginning interferon beta therapy, headache frequency and duration increased in 18% of all and in 35% of patients with pre-existing headache by more than 50% during the first 6 months. In two retrospective groups, increased headache frequency was reported by 34% of 53 patients on interferon beta, but by only 6% of 49 patients during at least 6 months of glatiramer acetate therapy.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Peptídeos
/
Adjuvantes Imunológicos
/
Interferon beta
/
Cefaleia
/
Esclerose Múltipla
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article